Pfizer Inc. (NYSE: PFE) made a strong move higher after it became the first drug manufacturer to sign on as part of the ...

The United States is poised to get a third coronavirus vaccine -- this one made by Johnson & Johnson. The US Food and Drug Administration has given the vaccine emergency use authorization, the Centers ...

Split of unit making knee and hip replacements comes as US healthcare group seeks shift to higher-growth areas ...

Johnson & Johnson reported third-quarter sales of $24 billion, beating the FactSet consensus estimate of $23.8 billion.

Johnson & Johnson's Q3 2025 earnings beat forecasts, with strong oncology sales and raised guidance. Click for my updated ...

Johnson & Johnson ranks highest in Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.

If Pfizer is successful, consumers may find it harder to hold drug makers accountable for inadequate warning labels.

J&J reports today, just two weeks after Pfizer secured certainty on tariffs and drug pricing. Analysts expect to hear about ...

Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after ...